The primary mechanism of GLP-1 analogs involves increasing insulin synthesis in response to hyperglycemia, reducing glucagon secretion in both hyperglycemic and euglycemic states, and slowing gastric emptying [1]. This evidence concerns the gene GLP1R and Hyperglycemia.